<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY UNAUDITED FINANCIAL INFORMATION EXTRACTED FROM
NOVEEN PHARMACEUTICALS, INC. FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2000
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.

<MULTIPLIER> 1,000

                             
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          20,800
<SECURITIES>                                         0
<RECEIVABLES>                                    6,898
<ALLOWANCES>                                       141
<INVENTORY>                                      5,338
<CURRENT-ASSETS>                                35,565
<PP&E>                                          22,349
<DEPRECIATION>                                   6,947
<TOTAL-ASSETS>                                  70,539
<CURRENT-LIABILITIES>                           11,018
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             2
<OTHER-SE>                                      70,468
<TOTAL-LIABILITY-AND-EQUITY>                    70,539
<SALES>                                         30,807
<TOTAL-REVENUES>                                31,247
<CGS>                                           13,951
<TOTAL-COSTS>                                   29,007
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 773
<INCOME-PRETAX>                                  9,396
<INCOME-TAX>                                       470
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     8,926
<EPS-BASIC>                                        .41
<EPS-DILUTED>                                      .39